Scleroderma

  • Ronald A. Asherson
  • Stephen H. Morgan
  • Graham R. V. Hughes
Chapter

Abstract

Scleroderma (progressive systemic sclerosis — PSS) is a generalized disorder of connective tissue characterized by fibrosis and subsequently damaging degenerative and atrophic complications. The disease is dominated by its cutaneous manifestations which may be mimicked by a number of other pathological conditions. A broad classification of sclerodermatous conditions is shown in Table 6.0.

Keywords

Interstitial Lung Disease Systemic Sclerosis Connective Tissue Disease Retroperitoneal Fibrosis Malignant Hypertension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Willscher M K, Novicki D E and Cwazka W F. Association of HLA-B27 antigen with retroperitoneal fibrosis. J. Urol 1978: 120 631–633.PubMedGoogle Scholar
  2. 2.
    Rabin B S, Rednan G B, Basjian S and Gill T J HLA antigens in progressive systemic sclerosis Arthritis Rheum 1975: 18 381–382.PubMedCrossRefGoogle Scholar
  3. 1.
    Clements P J, Furst D E and Cabeen W et al The relationship of arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis Am. J. Med 1981: 71 38–46.PubMedCrossRefGoogle Scholar
  4. 2.
    Bulbley B H, Rudolf R L, Salyer W R et al Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction Circulation 1976: 53 483–490.Google Scholar
  5. 3.
    Wasner C, Coobe C R and Fres J F Successful medical treatment of scleroderma renal crisis N. Engl. J. Med 1978: 299 873–875.PubMedCrossRefGoogle Scholar
  6. 4.
    Traub Y M, Shapiro A P, Rodnan G P et al Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a twenty-five year experience with sixty-eight cases Medicine (Baltimore) 1983: 62 335–352.Google Scholar
  7. 5.
    Cannon P J, Hassar M, Case D B et al The relationship of hypertension and renal failure in scleroderma to structural and functional abnormalities of the renal cortical circulation Medicine (Baltimore) 1974: 53 1–46.CrossRefGoogle Scholar
  8. 1.
    Barrett A J and Gordon-Smith E C Bone Marrow Transplantation, A Review 1983 (Oxford Medicine Publishing Foundation).Google Scholar
  9. 2.
    Denman A H Graft versus host diseases: new versions of old problems Br. Med. J 1985: 290 658–660.CrossRefGoogle Scholar
  10. 3.
    Harper J I Cutaneous graft versus host disease Br. Med. J 1987: 295 401–402.CrossRefGoogle Scholar
  11. 4.
    Deeg H J, Storb R and Thomas E D Bone marrow transplantation. A review of delayed complications Br. J. Haematol 1984: 57 185–208.PubMedGoogle Scholar
  12. 5.
    Graham-Brown R A C and Sarkany I Scleroderma-like changes due to chronic graft-versus-host disease Clin. Exp. Dermatol 1983: 8 531–538.PubMedCrossRefGoogle Scholar
  13. 1.
    D’Angelo W A Progressive systemic sclerosis: management. 1. Introduction and general commentary Clin. Rheum. Dis 1979: 5 263–276.Google Scholar
  14. 2.
    Winkelmann R K Classification and pathogenesis of scleroderma Mayo Clin. Proc 1971: 46 83–91.PubMedGoogle Scholar
  15. 3.
    Rocco V K and Hurd E R Scleroderma and scleroderma-like disorders Semin. Arthritis Rheum 1986: 16 22–69.PubMedCrossRefGoogle Scholar
  16. 4.
    Reichlin Y, Maddison P S, Targoff I et al. Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes J. Clin. Immunol 1984: 4 40–44.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1988

Authors and Affiliations

  • Ronald A. Asherson
  • Stephen H. Morgan
  • Graham R. V. Hughes

There are no affiliations available

Personalised recommendations